DEC group
|
Susceptibility, n (%)
|
---|
AMK
|
AMP
|
AMC
|
CTX
|
CHL
|
CIP
|
GEN
|
IPM
|
SXT
|
TET
|
TIC
|
---|
EAEC
|
Children (n = 30)
|
1 (3.3)
|
0
|
0
|
0
|
0
|
1 (3.3)
|
1 (3.3)
|
0
|
0
|
1 (3.3)
|
0
|
Adults (n = 46)
|
1 (2.2)
|
2 (4.3)
|
3 (6.5)
|
4 (8.7)
|
2 (4.3)
|
3 (6.5)
|
2 (4.3)
|
2 (4.3)
|
2 (4.3)
|
5 (10.9)
|
2 (4.3)
|
DAEC
|
Children (n = 18)
|
2 (11.1)
|
7 (38.9)
|
0
|
8 (44.4)
|
3 (16.7)
|
10 (55.5)
|
0
|
0
|
4 (22.2)
|
1 (5.5)
|
3 (16.7)
|
Adults (n = 24)
|
5 (20.8)
|
11 (45.8)
|
2 (8.3)
|
14 (58.3)
|
4 (16.7)
|
14 (58.3)
|
0
|
4 (16.7)
|
5 (20.8)
|
2 (8.3)
|
4 (16.7)
|
aEPEC
|
Children (n = 8)
|
4 (50.0)
|
6 (75.0)
|
3 (37.5)
|
6 (75.0)
|
5 (62.5)
|
5 (62.5)
|
5 (62.5)
|
5 (62.5)
|
6 (75.0)
|
5 (62.5)
|
5 (62.5)
|
Adults (n = 2)
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
-
AMK Amikacin, AMP Ampicillin, AMC Amoxicillin-Clavulanic acid, CTX Cefotaxime, CLO Choramphenicol, CIP Ciprofloxacin, GEN Gentamicin, IPM Imipenem, SUT trimethoprim-sulfamethoxazole, TET Tetracycline, TIC Ticarcillin